United Therapeutics enters $477.6M accelerated share repurchase with Citi

United Therapeutics entered into an accelerated share repurchase agreement with Citi to repurchase approximately $477.6 million of its common stock under its existing buyback program. The company will make an upfront payment of about $477.6 million around Sep 10, 2026 and receive an initial deliver…